全文获取类型
收费全文 | 28328篇 |
免费 | 1874篇 |
国内免费 | 280篇 |
专业分类
耳鼻咽喉 | 541篇 |
儿科学 | 364篇 |
妇产科学 | 378篇 |
基础医学 | 4646篇 |
口腔科学 | 830篇 |
临床医学 | 2554篇 |
内科学 | 5498篇 |
皮肤病学 | 1044篇 |
神经病学 | 2108篇 |
特种医学 | 1662篇 |
外科学 | 3478篇 |
综合类 | 157篇 |
现状与发展 | 3篇 |
一般理论 | 8篇 |
预防医学 | 1144篇 |
眼科学 | 497篇 |
药学 | 2668篇 |
中国医学 | 426篇 |
肿瘤学 | 2476篇 |
出版年
2023年 | 210篇 |
2022年 | 736篇 |
2021年 | 1090篇 |
2020年 | 589篇 |
2019年 | 805篇 |
2018年 | 946篇 |
2017年 | 753篇 |
2016年 | 1105篇 |
2015年 | 1505篇 |
2014年 | 1577篇 |
2013年 | 1887篇 |
2012年 | 2695篇 |
2011年 | 2497篇 |
2010年 | 1519篇 |
2009年 | 1200篇 |
2008年 | 1656篇 |
2007年 | 1457篇 |
2006年 | 1250篇 |
2005年 | 1180篇 |
2004年 | 938篇 |
2003年 | 831篇 |
2002年 | 680篇 |
2001年 | 409篇 |
2000年 | 394篇 |
1999年 | 314篇 |
1998年 | 161篇 |
1997年 | 140篇 |
1996年 | 95篇 |
1995年 | 74篇 |
1994年 | 80篇 |
1993年 | 67篇 |
1992年 | 114篇 |
1991年 | 131篇 |
1990年 | 114篇 |
1989年 | 98篇 |
1988年 | 92篇 |
1987年 | 79篇 |
1986年 | 79篇 |
1985年 | 63篇 |
1984年 | 42篇 |
1983年 | 38篇 |
1979年 | 55篇 |
1978年 | 39篇 |
1977年 | 28篇 |
1975年 | 53篇 |
1974年 | 30篇 |
1972年 | 39篇 |
1971年 | 49篇 |
1970年 | 34篇 |
1968年 | 31篇 |
排序方式: 共有10000条查询结果,搜索用时 14 毫秒
111.
Prognostic significance of c-kit mutation in localized gastrointestinal stromal tumors. 总被引:16,自引:0,他引:16
Tae Won Kim Hyoungnam Lee Yoon-Koo Kang Mi Sun Choe Min-Hee Ryu Heung Moon Chang Jung Sun Kim Jeong Hwan Yook Byung Sik Kim Jung Shin Lee 《Clinical cancer research》2004,10(9):3076-3081
PURPOSE: Constitutive mutational activation of c-kit has been found to be associated with the pathogenesis of gastrointestinal stromal tumors (GISTs). The prognostic significance of c-kit mutations, however, is still controversial. EXPERIMENTAL DESIGN: We examined 86 patients curatively resected for localized GIST. Genomic DNA was extracted from paraffin-embedded tumor tissues. Exons 9, 11, 13, and 17 of the c-kit gene were amplified by PCR and sequenced. RESULTS: Mutations in exon 11 were detected in 61 tumors, and mutations in exon 9 were observed in three tumors, whereas no mutations were detected in exons 13 or 17. The overall c-kit mutation frequency was 74%. Amino acid alterations in the 61 tumors with exon 11 mutations were deletion in 33 tumors, substitution in 20, both deletion and substitution in 4, insertion in 1, and duplication in 3. Histologically, tumors with c-kit mutations showed higher mitotic counts and higher cellularity. The 5-year relapse-free survival (RFS) in patients having GISTs with c-kit mutations was 21%, compared with 60% in those without c-kit mutations. Significantly higher RFS rates were observed in patients with tumors having mitotic counts < 5 mitoses/50 high power field, spindle-cell histology, tumor size < 5 cm, or gastric GISTs. Multivariate analyses indicated association of poorer RFS with a higher mitotic count > or = 5 of 50 high power fields; odds ratio (OR) = 3.0], presence of c-kit mutations (OR = 5.6), and a larger tumor size (> or = 5 cm; OR = 4.2). CONCLUSIONS: The presence of c-kit mutation, along with high mitotic count and larger tumor size, was an independent factor for poor prognosis in patients with localized GISTs. 相似文献
112.
Expression of placental growth factor gene in lung cancer. 总被引:4,自引:0,他引:4
In Sook Woo Myung Jae Park Jae Ho Byun Young Seon Hong Kyung Shik Lee Young Suk Park Jung Ae Lee Young Iee Park Hye-Kyung Ahn 《Tumour biology》2004,25(1-2):1-6
Differences in the gene expression profiles in small cell lung cancers (SCLC) and non-small cell lung cancers (NSCLC) may explain their different clinical characteristics. The aims of this study were (1) to identify genes differentially expressed in SCLC and NSCLC using mRNA differential display, and (2) to determine the clinical relevance of such genes in lung cancer. RNA differential display using three SCLC and six non-SCLC cell lines was used to identify a differentially expressed gene. Differential expression of the gene was confirmed in additional lung cancer cell lines using RT-PCR. Immunohistochemical staining for the gene product was performed on paraffin-embedded tissue from lung cancer patients. We examined the relationship between the expression of the gene and clinical parameters, including disease stage, response to treatment and survival time. The placental growth factor (PGF) gene was identified as preferentially expressed in SCLC compared with NSCLC cell lines using mRNA differential display. Further analysis of 45 lung cancer cell lines using RT-PCR showed that the placental growth factor (PGF) gene was expressed in nine of 13 SCLC cell lines (69%) and five of 32 NSCLC cell lines (15.6%) (p < 0.001, Fisher's exact test). Immunohistochemistry using anti-PGF antibody on the paraffin blocks from lung cancer patients showed that PGF expression was significantly higher in SCLC than NSCLC tissue sections (32 vs. 5.6%, p = 0.041, Fisher's exact test). Expression of PGF protein did not correlate with disease stage, response to treatment or survival time in SCLC patients. The present study suggests there is higher expression of PGF in SCLC compared to NSCLC. It may be that higher expression of the angiogenic factor PGF contributes to differences between the progression of SCLC and NSCLC, especially in regard to the nature of SCLC metastasis. 相似文献
113.
Prim?re und sekund?re Lebermalignome z?hlen weltweit zu den h?ufigsten Tumoren. Metastasen kommen hierbei etwa 30-mal h?ufiger
vor als hepatozellul?re Karzinome [4]. Die H?ufigkeit metastatischer Tumorabsiedlungen erkl?rt sich aus der topographisch-funktionellen
Lage der Leber als Bindeglied zwischen dem portalen und kavalen Kreislaufsystem. Abh?ngig von der Art des Prim?rtumors liegen
die Angaben über das Auftreten einer Lebermetastasierung zwischen 30 und 80%[4, 16].
Die Therapie von Lebertumoren hat sich entscheidend weiterentwickelt. In den letzten 20 Jahren etablierte sich mit der Verbesserung
der Operationstechniken – verbunden mit einer Senkung der Operationsletalit?t – eine zunehmend aggressive chirurgische Therapie
mit potenziell kurativer Zielsetzung in der Behandlung von Lebertumoren.Auch die chemotherapeutischen Verfahren und in den
letzten Jahren insbesondere die interventionellen Therapiem?glichkeiten der Lebertumoren wurden weiterentwickelt. Insofern
ist eine genaue Bild gebende Diagnostik zur ad?quaten Therapieplanung von gro?er Bedeutung.
Priv.-Doz.Dr. G.Jung Institut für Diagnostische Radiologie, Heinrich-Heine-Universit?t Düsseldorf, Moorenstra?e 5, 40225 Düsseldorf, E-Mail: Jung@med.uni-duesseldorf.de 相似文献
114.
Phytosphingosine induces apoptotic cell death via caspase 8 activation and Bax translocation in human cancer cells. 总被引:6,自引:0,他引:6
Moon-Taek Park Jung A Kang Jung-A Choi Chang-Mo Kang Tae-Hwan Kim Sangwoo Bae Seongman Kang Sujong Kim Weon-Ik Choi Chul-Koo Cho Hee-Yong Chung Yun-Sil Lee Su-Jae Lee 《Clinical cancer research》2003,9(2):878-885
PURPOSE: Sphingolipid metabolites, such as sphingosine and ceramide, are highly bioactive compounds and are involved in diverse cell processes, including cell-cell interaction, cell proliferation, differentiation, and apoptosis. However, the physiological roles of phytosphingosine are poorly understood. In this study, we report that phytosphingosine can potently induce apoptotic cell death in human cancer cells via caspase activation and caspase-independent cytochrome c release. EXPERIMENTAL DESIGN: Phytosphingosine-induced apoptosis was determined by Hoechst 33258 staining, flow cytometric analysis, and DNA fragmentation assay. Involvement of caspases was determined by immunoblot analysis and cell death detection assays after treatment with synthetic inhibitor z-Val-Ala-Asp-fluoromethyl ketone, z-DEVD-fmk, or z-IETD-fmk. Death receptor (DR) dependency was analyzed by examining expression of DRs (Fas, DR4, DR5, TNFR1, and R2), and interaction of Fas-associated death domain and caspase 8. Involvement of the mitochondria pathway was examined by monitoring of the mitochondria membrane potential, cytochrome c release, and Bax translocation. RESULTS: Phytosphingosine-treated cells displayed several features of apoptosis, including increase of sub-G(1) population, DNA fragmentation, and poly(ADP-ribose) polymerase cleavage. We observed that phytosphingosine cause activation of caspase 8 in a DR-independent fashion. Phytosphingosine also induced activation of caspase 9 and 3, loss of mitochondrial membrane potential, and the cytochrome c release from mitochondria. However, we failed to detect Bid cleavage. Moreover, caspase 8 inhibitor z-IETD-fmk did not affect phytosphingosine-induced cytochrome c release and caspase 9 activation, suggesting that phytosphingosine-induced cytochrome c release is caused by caspase 8-independent manner. Phytosphingosine induced mitochondrial translocation of Bax from the cytosol without changes in the protein levels of Bcl-2, Bcl-xL, and Bax. In addition, Bcl-2/Bax interaction was diminished after addition of phytosphingosine. CONCLUSION: These findings indicate that phytosphingosine induces apoptotic cell death in human cancer cells by direct activation of caspase 8, and by mitochondrial translocation of Bax and subsequent release of cytochrome c into cytoplasm, providing a potential mechanism for the anticancer activity of phytosphingosine. 相似文献
115.
Ravi Salgia Thomas Lynch Arthur Skarin Joan Lucca Cathleen Lynch Ken Jung F Stephen Hodi Michael Jaklitsch Steve Mentzer Scott Swanson Jean Lukanich Raphael Bueno John Wain Douglas Mathisen Cameron Wright Panos Fidias Dean Donahue Shirley Clift Steve Hardy Donna Neuberg Richard Mulligan Iain Webb David Sugarbaker Martin Mihm Glenn Dranoff 《Journal of clinical oncology》2003,21(4):624-630
PURPOSE: We demonstrated that vaccination with irradiated tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor (GM-CSF) stimulates potent, specific, and long-lasting antitumor immunity in multiple murine models and patients with metastatic melanoma. To test whether this vaccination strategy enhances antitumor immunity in patients with metastatic non-small-cell lung cancer (NSCLC), we conducted a phase I clinical trial. PATIENTS AND METHODS: Resected metastases were processed to single-cell suspension, infected with a replication-defective adenoviral vector encoding GM-CSF, irradiated, and cryopreserved. Individual vaccines consisted of 1 x 10(6), 4 x 10(6), or 1 x 10(7) cells, depending on overall yield, and were administered intradermally and subcutaneously at weekly and biweekly intervals. RESULTS: Vaccines were successfully manufactured for 34 (97%) of 35 patients. The average GM-CSF secretion was 513 ng/10(6) cells/24 h. Toxicities were restricted to grade 1 to 2 local skin reactions. Nine patients were withdrawn early because of rapid disease progression. Vaccination elicited dendritic cell, macrophage, granulocyte, and lymphocyte infiltrates in 18 of 25 assessable patients. Immunization stimulated the development of delayed-type hypersensitivity reactions to irradiated, dissociated, autologous, nontransfected tumor cells in 18 of 22 patients. Metastatic lesions resected after vaccination showed T lymphocyte and plasma cell infiltrates with tumor necrosis in three of six patients. Two patients surgically rendered as having no evidence of disease at enrollment remain free of disease at 43 and 42 months. Five patients showed stable disease durations of 33, 19, 12, 10, and 3 months. One mixed response was observed. CONCLUSION: Vaccination with irradiated autologous NSCLC cells engineered to secrete GM-CSF enhances antitumor immunity in some patients with metastatic NSCLC. 相似文献
116.
Cowling T Jennings LW Jung GS Goldstein RM Molmenti E Gonwa TA Klintmalm GB Levy MF 《Clinical transplantation》2000,14(2):115-120
The overall success of orthotopic liver transplantation (OLTX) includes not only survival, but quality of life (QOL) as well. We studied one controversial group of OLTX recipients, patients transplanted for alcoholic liver disease (Laennec's), to determine if their post-OLTX QOL was similar to that of patients transplanted for non-alcoholic liver disease (non-Laennec's). Over a 10-yr period, patients undergoing OLTX at our institution were asked to complete a QOL questionnaire addressing a wide range of topics from demographics and employment to symptom distress/frequency, activities of daily living, and effect of loss of health on daily life. Twenty-four Laennec's and 100 non-Laennec's OLTX recipients completed the questionnaire at both their 2- and 5-yr follow-up visits at our institution. Both groups were well-matched in age, race, and patient location status at the time of OLTX. No significant differences could be detected between Laennec's and non-Laennec's scores regarding overall QOL, including one's ability to function, health perception, and self-perception at 2 and 5 years post-OLTX, and between 2 and 5 years post-OLTX. Although not between groups, a significant difference was noted regarding patients' satisfaction with life, with less satisfaction reported at the 5-yr versus the 2-yr time point post-OLTX. Rates of current/recent employment between both groups were also similar at 2 years post-OLTX, and again at 5 years post-OLTX. We conclude that overall QOL and employment levels appear similar between patients transplanted for alcoholic and non-alcoholic liver disease. This similarity appears to extend to 5 years post-OLTX. 相似文献
117.
118.
119.
120.